UCLA
A five-year, $4.6 million NCI grant will help the researchers advance their EFIRM electric field-based DNA detection platform toward potential regulatory approval.
The device, which relies on magnets to move small amounts of fluid into different reaction chambers, can perform multiplexing and pooled testing.
UCLA researchers developed an extracellular vesicle-based surface protein assay for early-stage hepatocellular carcinoma.
Investigators See Future for NanoVelcro Cell Technology in Diagnosis of Pregnancy Complications
Premium
Researchers demonstrated that detection of single and clustered circulating trophoblasts could reliably differentiate placenta accreta from normal controls and other disorders, even early in gestation.
Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection
The researchers will compare saliva and plasma samples from 50 patients with non-small cell lung cancer to identify circulating tumor DNA in saliva.